Heron Therapeutics Inc (NASDAQ:HRTX)

8.20
Data as of 2:06pm ET
 -0.16 / -1.91%
Today’s Change
6.51
Today|||52-Week Range
15.82
-18.49%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 19.00, with a high estimate of 40.00 and a low estimate of 16.00. The median estimate represents a +131.71% increase from the last price of 8.20.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.79
Sales
$0.00
Reporting Date
Mar 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -19.39%
 
 
 
 
 
 
Growthannually 13.10%
 
 
 
 
 

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.